Amino Acid Analysis: The Test That Gives Net Peptide Content
Net peptide content is the mass fraction of a powder that is peptide, as opposed to counter-ions, residual water, salts and residual solvent. Reverse-phase HPLC cannot report it, because HPLC compares peptide-related peaks against each other and never weighs the non-peptide mass. Quantitative amino acid analysis is the method that does: the chain is hydrolysed to free amino acids, those amino acids are quantified against calibration standards, and the peptide mass is reconstructed from them.
A vial labelled 10 mg contains 10 mg of powder. How much of that powder is peptide is a separate question with a separate answer, and the two are routinely conflated. Trifluoroacetate counter-ions left from purification, water bound in the lyophilized cake, acetate or chloride in a salt-exchanged material and any bulking agent all add mass without adding peptide.
Reverse-phase HPLC at 214 nm reports a relative area: the main peak as a percentage of the total integrated area of all peaks that absorb at that wavelength. Counter-ions and water do not absorb at 214 nm in any meaningful way, so they are invisible to the measurement. A material can be 99.1% pure by RP-HPLC area at 214 nm and 81% peptide by mass at the same time, with no contradiction between the two figures.
Quantitative amino acid analysis, usually written AAA, closes the gap between purity and peptide content. It is a destructive mass-based assay rather than a separation, and it is the reference method behind most peptide content specifications in the pharmacopoeias.
How the measurement is made
The sequence is hydrolysis, derivatisation, separation, then arithmetic. A weighed portion of powder is hydrolysed in 6 M hydrochloric acid at 110 °C for 24 hours under vacuum or nitrogen, which cleaves every peptide bond and leaves a mixture of free amino acids. That mixture is derivatised, commonly with ninhydrin post-column or with ortho-phthalaldehyde or phenyl isothiocyanate pre-column, separated by ion-exchange or reverse-phase chromatography, and each residue is quantified against a calibrated amino acid standard mixture.
The recovered molar amounts are then compared with the composition the sequence predicts. A chain containing three glycine residues should return three times the molar quantity of glycine as a chain position present once. Scaling the recovered moles by the residue masses and dividing by the mass of powder taken gives net peptide content as a percentage by mass.
| Method | Quantity reported | Blind to |
|---|---|---|
| RP-HPLC, 214 nm, area percent | Main peak as a share of peptide-related peak area | Counter-ions, water, salts, non-absorbing excipients |
| Quantitative AAA after 6 M HCl hydrolysis, 110 °C, 24 h | Peptide mass as a percentage of powder mass, typically 70 to 90% for a TFA salt | Which impurity peaks are present, and sequence order |
| Karl Fischer titration | Water content by mass, commonly 1 to 8% w/w in a lyophilized cake | Everything that is not water |
| Ion chromatography for TFA | Trifluoroacetate by mass, often 5 to 20% w/w before salt exchange | Everything that is not the counter-ion measured |
The three mass-based columns are complementary rather than redundant. Net peptide content from AAA, water from Karl Fischer and counter-ion from ion chromatography should account for most of the powder between them, and a large unexplained remainder is itself a finding.
The failure mode: residues that do not survive hydrolysis
Acid hydrolysis at 110 °C for 24 hours is harsh by design, and several residues do not come through it intact. Tryptophan is largely destroyed. Cysteine and methionine are partly oxidised unless the sample is protected, commonly by performic acid oxidation before hydrolysis so that cysteine is counted as cysteic acid and methionine as methionine sulfone. Asparagine and glutamine are deamidated to aspartate and glutamate during hydrolysis, so the two pairs cannot be distinguished and are reported as Asx and Glx. Serine and threonine show partial losses in the range of a few percent.
The consequence is specific: if the content calculation is anchored on a labile residue, the answer comes out low, and a laboratory that quotes net peptide content without saying which residues it anchored on has not given a checkable number. A tryptophan-containing chain quantified against tryptophan recovery can under-report peptide content by tens of percent. The convention is to anchor on stable residues, glycine, alanine, leucine, valine, phenylalanine and lysine among them, and to report the anchor set.
Why the arithmetic is sensitive to the weighing step
Net peptide content is a ratio with the mass of powder taken in the denominator, and lyophilized peptide is hygroscopic. A cake left open to laboratory air at 50% relative humidity gains water within minutes, which inflates the denominator and depresses the reported content. Weighing is therefore done quickly, or in a controlled-humidity enclosure, and the water figure used in any back-calculation has to come from the same sampling occasion.
- Hydrolysis conditions: 6 M HCl, 110 °C, 24 h is the classical condition. Shorter or microwave-assisted variants exist and give different recovery profiles, so the condition belongs in the record.
- Anchor residues: which residues the content calculation was built on, and which were excluded as labile.
- Replicates: content is normally the mean of at least two independent hydrolysates, because a single hydrolysis carries the full weight of one weighing error.
- Reporting basis: as-is, or corrected to an anhydrous and counter-ion-free basis. The two differ by the whole water and salt fraction.
What Aurum does and does not measure
Aurum publishes chromatographic purity figures. Those are HPLC purity, an area percentage at a stated wavelength, and they are not net peptide content. Quantitative amino acid analysis is not among the specifications Aurum publishes, so where a research question depends on knowing the absolute peptide mass in a vial rather than the relative purity of the peptide present, our published figure does not answer it and should not be read as though it does.
The same boundary applies to counter-ion and water content. Unless a figure for those is stated explicitly for a lot, the relationship between powder mass and peptide mass in that lot is unquantified by us. Saying so is more useful than implying a precision we have not measured.
Common questions
Is net peptide content the same as purity?
No. Purity is a ratio among peptide-related species. Net peptide content is a ratio of peptide mass to total mass. A material can score high on one and low on the other.
Can a UV absorbance reading substitute for AAA?
Only for chains containing tryptophan, tyrosine or cystine, and only within the accuracy of the calculated extinction coefficient at 280 nm, which is typically quoted to around 5% for tyrosine-bearing chains and worse where the chromophore count is low. Chains with no aromatic residue give no usable signal at 280 nm at all.
Why are asparagine and glutamine reported together with aspartate and glutamate?
Because acid hydrolysis converts the amides to the corresponding acids. The method cannot tell which form was present in the intact chain, so the pairs are summed as Asx and Glx.
How much material does the test consume?
The assay is destructive. Typical sample requirements are in the tens to low hundreds of micrograms per hydrolysate, plus replicates, so a small vial can be materially depleted by a full determination.
Does a higher net peptide content mean a better material?
It means less non-peptide mass per unit of powder. It says nothing about which peptide-related impurities are present, which is a separate measurement.
References
- 01United States Pharmacopeia General Chapter <1052> Biotechnology-Derived Articles: Amino Acid Analysis. USP–NF.
- 02European Directorate for the Quality of Medicines General Chapter 2.2.56 Amino Acid Analysis. European Pharmacopoeia.
- 03United States Pharmacopeia General Chapter <921> Water Determination. USP–NF.
- 04International Council for Harmonisation Q3C Impurities: Guideline for Residual Solvents. ICH Harmonised Guideline.
- 05International Council for Harmonisation Q6B Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products. ICH Harmonised Guideline.
- 06United States Pharmacopeia General Chapter <1225> Validation of Compendial Procedures. USP–NF.
Every citation links out to the paper on PubMed. Identifiers are omitted deliberately rather than reproduced from memory, so where we do not hold a verified PMID or DOI the link is a PubMed search for that exact title — it resolves to the paper without anything being invented.
FOR RESEARCH USE ONLY · NOT INTENDED FOR HUMAN CONSUMPTION. This article describes compounds and the research literature in which they appear. Nothing here is a recommendation, protocol, or statement of effect.